comparemela.com

Latest Breaking News On - Enanta pharmaceuticals - Page 1 : comparemela.com

Other Barks & Bites for Friday, May 31: Senator Asks USCO to Expand DMCA Exemption for Security Research on Generative AI; WIPO Adopts Historic Treaty; and the United States and Japan Lead the Pack in Alternative Protein Patent Applications

Other Barks & Bites for Friday, May 31: Senator Asks USCO to Expand DMCA Exemption for Security Research on Generative AI; WIPO Adopts Historic Treaty; and the United States and Japan Lead the Pack in Alternative Protein Patent Applications
ipwatchdog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipwatchdog.com Daily Mail and Mail on Sunday newspapers.

White-house
District-of-columbia
United-states
Fiji
Germany
China
Riga
Latvia
New-york
Massachusetts
Japan
Switzerland

Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L..

New-york
United-states
Taral-kieffer
Nasdaq
Enanta-pharmaceuticals-to
Enanta-pharmaceuticals-inc
Jefferies-global-healthcare
Chief-executive-officer
Chief-product-strategy-officer
Jefferies-global-healthcare-conference
Enanta-pharmaceuticals

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $19.00 Consensus Price Target from Brokerages

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the […]

Enanta-pharmaceuticals-stock-performance
Jpmorgan-chase-co
News-ratings-for-enanta-pharmaceuticals-daily
Hermes-inc
Nasdaq
Acadian-asset-management
Vanguard-group-inc
Analyst-recommendations-for-enanta-pharmaceuticals
Enanta-pharmaceuticals-company-profile
Enanta-pharmaceuticals-inc
Enanta-pharmaceuticals

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $19.00 Average Target Price from Brokerages

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been assigned an average rating of “Hold” from the six ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to […]

Florida
United-states
News-ratings-for-enanta-pharmaceuticals-daily
Clearstead-advisors
Institutional-trading-of-enanta-pharmaceuticals
Enanta-pharmaceuticals-inc
Sherbrooke-park-advisers
Enanta-pharmaceuticals-stock-performance
Analyst-recommendations-for-enanta-pharmaceuticals
Nasdaq
Enanta-pharmaceuticals

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Hold" from Analysts

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned an average rating of “Hold” from the six analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. […]

Acadian-asset-management
Enanta-pharmaceuticals-inc
Nasdaq
Armistice-capital
Enanta-pharmaceuticals-stock-performance
News-ratings-for-enanta-pharmaceuticals-daily
Jpmorgan-chase-co
Analyst-recommendations-for-enanta-pharmaceuticals
Enanta-pharmaceuticals
Institutional-investors-weigh-in-on-enanta-pharmaceuticals
Vanguard-group-inc

vimarsana © 2020. All Rights Reserved.